US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

2.5 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-297-02 D-1407-2016
Class II · Moderate risk Terminated

2.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-0972-48 D-1406-2016
Class II · Moderate risk Terminated

2.5 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-255-37 D-1405-2016
Class II · Moderate risk Terminated

2.5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-882-48 D-1404-2016
Class II · Moderate risk Terminated

2.5 mcg/mL Fentanyl Citrate and 0.0312% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-195-50 D-1403-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-103-52 D-1402-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-108-02 D-1401-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.167% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-276-98 D-1400-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.162% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-229-97 D-1399-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.16% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-102-48 D-1398-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-433-58 D-1397-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-125-52 D-1396-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-201-58 D-1395-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.083% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-871-48 D-1394-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-296-52 D-1393-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-226-98 D-1392-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-966-95 D-1391-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.06% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-095-50 D-1390-2016
Class II · Moderate risk Terminated

2 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-103-48 D-1389-2016
Class II · Moderate risk Terminated

16.67 mcg/mL Fentanyl Citrate and 0.1667% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-228-96 D-1388-2016
Class II · Moderate risk Terminated

10 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-908-02 D-1387-2016
Class II · Moderate risk Terminated

10 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-909-02 D-1386-2016
Class II · Moderate risk Terminated

10 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-480-50 D-1385-2016
Class II · Moderate risk Terminated

10 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl

Reason Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Pharmedium Services, LLC NDC 61553-733-20 D-1384-2016